Dipeptidyl peptidase 4 plays a vital role in the development of liver diseases, i.e., non-alcoholic fatty liver disease, hepatic steatosis and hepatocellular carcinoma [21–23]. Here, DPP4 is linked to metabolic dysfunction-associated steatotic liver disease.